Faricimab
Also known as Vabysmo (us)
Faricimab-svoa injection is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities), diabetic macular edema (DME; an eye disease caus…
Based on 30 units per month. US $44,393.84 vs India $700.72 per unit.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $7,864,761
- Estimated travel cost
- − $2,300
- Net savings after travel
- $7,862,461
Even after travel, you could come out ahead by about $7,862,461.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Faricimab is filled about 8.4K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.